Private Capital Advisors
GPCR icon

Private Capital Advisors’s Structure Therapeutics GPCR Stock Holding History

Private Capital Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$931K Hold
29,760
– – 0.08% 40
2026
Q2 		$1.6M Sell
29,760
-4,629
-13% -$205K 0.14% 36
2026
Q1 		$1.66M Buy
34,389
+27,041
+368% +$1.85M 0.19% 35
2025
Q4 		$511K Sell
7,348
-47,837
-87% -$1.95M 0.05% 52
2025
Q3 		$1.55M Buy
+55,185
New +$1.1M 0.17% 39

Other funds holding GPCR

Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Mission Wealth Management
Mission Wealth Management Santa Barbara, California $6.32B AUM 20.97% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Private Capital Advisors's GPCR Position: Q3 2026 in Review

Private Capital Advisors held its Structure Therapeutics (GPCR) position steady in Q3 2026 at 29,760 shares worth $931K. The position accounts for 0.08% of the portfolio, ranked #40.

Private Capital Advisors first reported a position in GPCR in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.66M in Q1 2026. 23 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Private Capital Advisors held 29,760 shares of Structure Therapeutics worth $931K as of Q3 2026.
  • Private Capital Advisors left its Structure Therapeutics share count unchanged in Q3 2026.
  • Structure Therapeutics made up 0.08% of Private Capital Advisors's portfolio in Q3 2026, its #40 holding.
  • Private Capital Advisors first reported a position in Structure Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Private Capital Advisors's Structure Therapeutics position peaked at $1.66M in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Private Capital Advisors's 13F filing for Q3 2026, filed 6 Oct 2026.